• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM Back to Search Results
Catalog Number 22437-19
Medical Device Problem Codes Break (1069); Stretched (1601); Material Too Soft/Flexible (4007)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/09/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was to treat an 80% stenosed lesion in the carotid artery.The small emboshield nav 6 embolic protection system (eps) was advanced to it's intended location; however, the physician noted that the eps did not feel as expected during advancement.Therefore, the eps was removed from the patient and the tip of the barewire was noted to have become unraveled.There was no adverse patient effect and no clinically significant delay reported in the procedure.Another emboshield nav 6 eps was used to continue the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
Visual analysis was performed on the returned device.The reported break to the barewire tip coils and stretching were confirmed.The reported unexpected feeling during advancement (material too soft/flexible) was unable to be confirmed as it was based on procedural circumstances due to the damage to the tip coils.Lot history record (lhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.The investigation determined that the reported barewire damage was likely due to circumstances of the procedure.It is likely that during advancement into the 80% stenosed lesion, the tip of the barewire likely became entrapped in the tight lesion resulting in the tip coil becoming stretched and the inner core to break.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM
Common Device Name
EMBOLIC PROTECTION SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key19222938
Report Number2024168-2024-05338
Device Sequence Number15207954
Product Code NTE
UDI-Device Identifier08717648137747
UDI-Public(01)08717648137747(17)261031(10)3111661
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
K141678
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number22437-19
Device Lot Number3111661
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/22/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/09/2024
Supplement Date Received by Manufacturer06/14/2024
Initial Report FDA Received Date05/01/2024
Supplement Report FDA Received Date06/17/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/16/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-